Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-06-12 17:32:55 UTC |
---|
Update Date | 2021-09-14 14:59:06 UTC |
---|
HMDB ID | HMDB0060540 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Norverapamil |
---|
Description | Norverapamil is a calcium channel blocker. It is the main active metabolite of verapamil. Verapamil (brand names: Isoptin, Verelan, Verelan PM, Calan, Bosoptin, Covera-HS) is an L-type calcium channel blocker of the phenylalkylamine class. It has been used in the treatment of hypertension, angina pectoris, cardiac arrhythmia, and most recently, cluster headaches. It is also an effective preventive medication for migraine. Verapamil has also been used as a vasodilator during cryopreservation of blood vessels. (Wikipedia ) |
---|
Structure | COC1=C(OC)C=C(CCNCCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1 InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3 |
---|
Synonyms | Value | Source |
---|
Norverapamil (6%) | HMDB | Norverapamil monohydrochloride | HMDB | Norverapamil, (+-)-isomer | HMDB | N-Demethylverapamil | HMDB |
|
---|
Chemical Formula | C26H36N2O4 |
---|
Average Molecular Weight | 440.575 |
---|
Monoisotopic Molecular Weight | 440.26750765 |
---|
IUPAC Name | 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(propan-2-yl)pentanenitrile |
---|
Traditional Name | norverapamil |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=C(OC)C=C(CCNCCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3 |
---|
InChI Key | UPKQNCPKPOLASS-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylbutylamines. Phenylbutylamines are compounds containing a phenylbutylamine moiety, which consists of a phenyl group substituted at the fourth carbon by an butan-1-amine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenylbutylamines |
---|
Direct Parent | Phenylbutylamines |
---|
Alternative Parents | |
---|
Substituents | - Phenylbutylamine
- Dimethoxybenzene
- O-dimethoxybenzene
- Phenethylamine
- Phenylpropane
- Anisole
- Phenol ether
- Phenoxy compound
- Methoxybenzene
- Alkyl aryl ether
- Aralkylamine
- Secondary amine
- Nitrile
- Carbonitrile
- Ether
- Secondary aliphatic amine
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Norverapamil,1TMS,isomer #1 | COC1=CC=C(CCN(CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)[Si](C)(C)C)C=C1OC | 3236.1 | Semi standard non polar | 33892256 | Norverapamil,1TMS,isomer #1 | COC1=CC=C(CCN(CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)[Si](C)(C)C)C=C1OC | 3477.2 | Standard non polar | 33892256 | Norverapamil,1TMS,isomer #1 | COC1=CC=C(CCN(CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)[Si](C)(C)C)C=C1OC | 4483.1 | Standard polar | 33892256 | Norverapamil,1TBDMS,isomer #1 | COC1=CC=C(CCN(CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)[Si](C)(C)C(C)(C)C)C=C1OC | 3490.1 | Semi standard non polar | 33892256 | Norverapamil,1TBDMS,isomer #1 | COC1=CC=C(CCN(CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)[Si](C)(C)C(C)(C)C)C=C1OC | 3608.9 | Standard non polar | 33892256 | Norverapamil,1TBDMS,isomer #1 | COC1=CC=C(CCN(CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)[Si](C)(C)C(C)(C)C)C=C1OC | 4481.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Norverapamil GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-5894400000-1905d27fda526950b48a | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norverapamil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 10V, Positive-QTOF | splash10-0006-0111900000-f6499f82af6436a7ffeb | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 20V, Positive-QTOF | splash10-02t9-0792400000-08e2f7e8c53985c53cee | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 40V, Positive-QTOF | splash10-014i-0972000000-08658a08d28032cd18b1 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 10V, Negative-QTOF | splash10-000i-0000900000-7ffe5e7bd99bb75f243a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 20V, Negative-QTOF | splash10-0080-0013900000-eca8291f2c7f6c6a2e58 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 40V, Negative-QTOF | splash10-00nf-0559300000-ff37eccd07a8565257b4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 10V, Positive-QTOF | splash10-0006-0100900000-49dae5e8c26055f14dfe | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 20V, Positive-QTOF | splash10-0006-3573900000-30f9b8c1942de6e2b083 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 40V, Positive-QTOF | splash10-0i09-0791100000-38ab31d93b0b16941a6b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 10V, Negative-QTOF | splash10-000i-0000900000-252ab6672a823d321850 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 20V, Negative-QTOF | splash10-057i-0009700000-66c7a6d4b2381a3754e1 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norverapamil 40V, Negative-QTOF | splash10-029l-0519200000-bab1f58bc74b461d1d19 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|